GLPwatch
Trials (2167)
Page 14 of 37.
- GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
- A Multiple-Dose Study of LY3502970 in Healthy Participants
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
- A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- Intravenous Exenatide in Patients With Acute Brain Injury
- A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
- Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
- A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
- Pharmacogenomics of GLP1 Receptor Agonists
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
- Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
- The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
- Semaglutide Treatment in Type 1 Diabetes
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
- SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
- Semaglutide Treatment On Coronary Progression
- Lecanemab for Early Onset Familial Alzheimer's Disease
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
- A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
- The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
- A Study of BGM0504 in Participants with Type 2 Diabetes
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
- Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
- Effects of Glucagon Like Peptide-1 on No-reflow
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- ECHO for Diabetes and Multiple Chronic Conditions Study
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- A Study of LY3457263 in Obese Participants
- A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
- Liraglutide as add-on to Insulin in Type 1 Diabetes
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
- Liraglutide In Overweight Patients With Type 1 Diabetes
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
- Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
- Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
- Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
- LY2189265 and Atorvastatin Interaction Study
- Semaglutide vs Sitagliptin
- Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
- Incretin-based Drugs and the Risk of Heart Failure
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.